HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

6.270

-0.535-7.86%

Volume:26.32M

Turnover:183.97M

Market Cap:2.38B

PE:-6.73

High:8.270

Open:7.825

Low:6.250

Close:6.805

52wk High:22.560

52wk Low:5.350

Shares:380.07M

HK Float Shares:375.46M

Volume Ratio:7.09

T/O Rate:7.01%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.932

ROE:-70.66%

ROA:-28.19%

PB:7.84

PE(LYR):-6.73

PS:19112.60

Loading ...

Overview Company News Filings

Regulatory Approval Granted to TY-9591, a Novel Targeted Therapy for EGFR-Mutant Lung Cancer With Brain Metastases

Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval

TYK MEDICINES-B Secures Conditional NMPA Approval for Its Novel EGFR-TKI Therapy

TYK Medicines Says China Regulator Grants Conditional Approval for TY-9591 Lung Cancer Drug

Tyk Medicines - Asandeutertinib Mesylate Tablets (Ty-9591) Obtains Conditional Marketing Approval from Nmpa

THOMSON REUTERS

TYK Medicines Extends Long-Stop Date for 63.22 Million H-Share Placement to 20 September 2026

Bulletin Express

Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up

TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward

TYK Medicines outlines 2026 board reshuffle, schedules vote on seven director re-elections

Bulletin Express

TYK Medicines FY26 H1 Comprehensive Loss Narrows 76.4% to RMB 26.88 Million

TYK Medicines Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management

TYK Medicines Non-Executive Director Jiang Mingyu Resigns, Wu Yusheng Named Authorized Representative

TYK Medicines Sets 17 August 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express

TYK Medicines Reports No Share Capital Changes in July 2026 Monthly Return

Bulletin Express

TYK Medicines Schedules Board Meeting to Review Interim Results, Consider Dividend

TYK Medicines-B Shares Surge Over 5% as Qilu Pharma Secures Exclusive Rights for Lung Cancer Drug TY-9591

TYK Medicines files dual court actions to invalidate alleged TY-9591 agreements with Sichuan Huiyu Pharmaceutical

Bulletin Express

TYK MEDICINES-B Initiates Legal Proceedings Against Sichuan Huiyu Pharmaceutical Co., Ltd.

Tyk Medicines - Files Legal Proceedings Against Sichuan Huiyu Pharmaceutical over Ty-9591 Agreements

THOMSON REUTERS

TYK Medicines Sues Huiyu Pharma over Disputed Ty-9591 Cooperation Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/02410/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":6.27,"timestamp":1787904513002,"preClose":6.805,"halted":0,"volume":26321500,"delay":0,"changeRate":-0.07861866274797945,"floatShares":375457818,"shares":380065818,"eps":-0.9322080692727616,"marketStatus":"Not Yet Opened","change":-0.535,"latestTime":"08-28 16:08:33","open":7.825,"high":8.27,"low":6.25,"amount":183972620,"amplitude":0.296841,"askPrice":6.28,"askSize":12500,"bidPrice":6.27,"bidSize":47500,"shortable":3,"etf":0,"ttmEps":-0.6543110175221184,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":6.805,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":7.0932144011117115,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-28.19%","roe":"-70.66%","lyrEps":-0.932208,"volumeRatio":7.0932144011117115,"shares":380065818,"dividePrice":0,"high":8.27,"amplitude":0.296841,"preClose":6.805,"low":6.25,"week52Low":5.35,"pbRate":"7.84","psRate":"19112.60","week52High":22.56,"institutionHeld":0,"latestPrice":6.27,"committee":0.583333,"eps":-0.9322080692727616,"divideRate":0,"volume":26321500,"delay":0,"ttmEps":-0.6543110175221184,"open":7.825,"prevYearClose":13.11,"prevWeekClose":6.665,"prevMonthClose":6.81,"prevQuarterClose":5.73,"fiveDayClose":6.665,"twentyDayClose":6.81,"sixtyDayClose":8.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-08-28","current":-9.582599,"percent":0.873239,"low":-45.171338,"twenty":-23.880566,"median":-17.053511,"eighty":-12.176647,"high":-6.195227,"avg":-18.025321,"sd":7.183078,"marketCap":2411904838},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306},{"date":"2026-03-06","current":-13.279596,"twenty":-24.77147,"median":-18.709822,"eighty":-15.892604,"marketCap":4218730579},{"date":"2026-03-13","current":-12.861452,"twenty":-24.760877,"median":-18.616931,"eighty":-15.828013,"marketCap":4104710834},{"date":"2026-03-20","current":-12.157235,"twenty":-24.758022,"median":-18.440891,"eighty":-15.765099,"marketCap":3865269369},{"date":"2026-03-27","current":-12.164275,"twenty":-24.758022,"median":-18.409208,"eighty":-15.692499,"marketCap":3857668052},{"date":"2026-04-02","current":-12.25818,"twenty":-24.73228,"median":-18.399621,"eighty":-15.606124,"marketCap":4180723998},{"date":"2026-04-10","current":-12.412577,"twenty":-24.72344,"median":-18.391406,"eighty":-15.554796,"marketCap":4266032641},{"date":"2026-04-17","current":-12.351427,"twenty":-24.717087,"median":-18.309793,"eighty":-15.461655,"marketCap":4246798950},{"date":"2026-04-24","current":-11.422185,"twenty":-24.709149,"median":-18.216326,"eighty":-15.337994,"marketCap":3927519681},{"date":"2026-04-30","current":-11.117278,"twenty":-24.702871,"median":-18.174743,"eighty":-15.304685,"marketCap":3823657750},{"date":"2026-05-08","current":-10.777891,"twenty":-24.684547,"median":-18.056929,"eighty":-15.189837,"marketCap":3719795820},{"date":"2026-05-15","current":-9.293361,"twenty":-24.617578,"median":-17.965815,"eighty":-15.119492,"marketCap":3215873118},{"date":"2026-05-22","current":-8.991533,"twenty":-24.605712,"median":-17.939574,"eighty":-15.043492,"marketCap":3104317711},{"date":"2026-05-29","current":-10.14843,"twenty":-24.599189,"median":-17.918048,"eighty":-14.961326,"marketCap":3515918696},{"date":"2026-06-05","current":-8.237808,"twenty":-24.571342,"median":-17.89208,"eighty":-14.895383,"marketCap":2858126467},{"date":"2026-06-12","current":-7.644268,"twenty":-24.535606,"median":-17.732128,"eighty":-14.684931,"marketCap":2650402606},{"date":"2026-06-18","current":-6.884404,"twenty":-24.459385,"median":-17.688347,"eighty":-14.384241,"marketCap":2392671147},{"date":"2026-06-26","current":-6.195227,"twenty":-24.397853,"median":-17.672452,"eighty":-13.470121,"marketCap":2142633166},{"date":"2026-07-03","current":-7.179757,"twenty":-24.364887,"median":-17.499062,"eighty":-13.369605,"marketCap":2484992864},{"date":"2026-07-10","current":-8.078806,"twenty":-24.314468,"median":-17.476751,"eighty":-13.262753,"marketCap":2792731918},{"date":"2026-07-17","current":-8.127776,"twenty":-24.232724,"median":-17.419476,"eighty":-13.079412,"marketCap":2819659085},{"date":"2026-07-24","current":-7.604914,"twenty":-24.150839,"median":-17.377721,"eighty":-12.93356,"marketCap":2638862391},{"date":"2026-07-31","current":-7.53517,"twenty":-24.119743,"median":-17.333807,"eighty":-12.87079,"marketCap":2619628700},{"date":"2026-08-07","current":-7.625479,"twenty":-24.07756,"median":-17.320685,"eighty":-12.528428,"marketCap":2656172713},{"date":"2026-08-14","current":-7.417307,"twenty":-24.00283,"median":-17.276309,"eighty":-12.375887,"marketCap":2586931426},{"date":"2026-08-21","current":-10.34776,"twenty":-23.939778,"median":-17.197085,"eighty":-12.303816,"marketCap":2563850996},{"date":"2026-08-28","current":-9.732294,"twenty":-23.880566,"median":-17.053511,"eighty":-12.176647,"marketCap":2411904838}],"updateTime":1788113243274},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160195838","title":"Regulatory Approval Granted to TY-9591, a Novel Targeted Therapy for EGFR-Mutant Lung Cancer With Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=1160195838","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160195838?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:32","pubTimestamp":1787884340,"startTime":"0","endTime":"0","summary":"On August 27, 2026, Hong Kong-listed innovative drug developer TYK Medicines-B (02410) announced that its independently developed Class 1 new drug, Dutersatinib mesylate tablets (TY-9591), received...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156832241","title":"Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1156832241","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156832241?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:41","pubTimestamp":1787881292,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) saw its shares surge nearly 15% in early trading, with the stock climbing 14.99% to HK$7.825 at the time of writing, on a turnover of HK$2.758 million.On the evening of August...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1161","LNGR","09939","BK1515","IBBQ","02410","IPOS","06978","159992","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191561333","title":"TYK MEDICINES-B Secures Conditional NMPA Approval for Its Novel EGFR-TKI Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191561333","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191561333?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:26","pubTimestamp":1787837163,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has announced that its independently developed next-generation EGFR-TKI innovative drug, Duxenaitinib Mesylate Tablets (TY-9591), has received conditional marketing approval...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02410","159938","IPOS","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088664","title":"TYK Medicines Says China Regulator Grants Conditional Approval for TY-9591 Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088664","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088664?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:17","pubTimestamp":1787836653,"startTime":"0","endTime":"0","summary":"TYK Medicines says China regulator grants conditional approval for TY-9591 lung cancer drugChina’s NMPA granted conditional marketing clearance for TY-9591, a next-generation EGFR-TKI, for first-line ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL7DjG9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662088571","title":"Tyk Medicines - Asandeutertinib Mesylate Tablets (Ty-9591) Obtains Conditional Marketing Approval from Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2662088571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662088571?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:16","pubTimestamp":1787836581,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162059231","title":"TYK Medicines Extends Long-Stop Date for 63.22 Million H-Share Placement to 20 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1162059231","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162059231?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:28","pubTimestamp":1787225297,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. has pushed back the long-stop date for completing its planned issuance of 63.22 million H shares under general mandate. According to an announcement dated 20 August 2026, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161497517","title":"Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1161497517","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161497517?lang=en_us&edition=fundamental","pubTime":"2026-08-18 11:11","pubTimestamp":1787022675,"startTime":"0","endTime":"0","summary":"TYK Medicines-B (02410) saw its share price rally more than 6% during the morning session, last trading 5.63% higher at HK$7.13 with turnover reaching HK$16.15 million.The company's interim results...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","BK1574","BK4588","BK1515","09939","TY","02410","BK4585","VXUS","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181695401","title":"TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=1181695401","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181695401?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:49","pubTimestamp":1786970980,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has reported its interim results for the 2026 fiscal year, revealing a substantial improvement in its financial performance. Research and development costs reached RMB 94.943...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02410","159938","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158885908","title":"TYK Medicines outlines 2026 board reshuffle, schedules vote on seven director re-elections","url":"https://stock-news.laohu8.com/highlight/detail?id=1158885908","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158885908?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:44","pubTimestamp":1786970690,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. has disclosed a forthcoming leadership transition and a planned board refresh. Key changes   • Non-executive director (NED) Dr. Jiang Mingyu will step down on 17 August 2026 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848081","title":"TYK Medicines FY26 H1 Comprehensive Loss Narrows 76.4% to RMB 26.88 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848081?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:34","pubTimestamp":1786970047,"startTime":"0","endTime":"0","summary":"TYK Medicines FY26 H1 comprehensive loss narrows 76.4% to RMB 26.88 millionTYK Medicines posted a total comprehensive loss of RMB 26.88 million, narrowing 76.4% from the year-earlier period.Loss attri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9X5R5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660876314","title":"TYK Medicines Files List of Directors, Board Committee Memberships and Disclosure-Responsible Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2660876314","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660876314?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:15","pubTimestamp":1786968931,"startTime":"0","endTime":"0","summary":"TYK Medicines files list of directors, board committee memberships and disclosure-responsible managementTYK Medicines named Dr. WU Yusheng as executive director.Non-executive directors: Dr. LI Jun, Dr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLyXhG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487885","title":"TYK Medicines Non-Executive Director Jiang Mingyu Resigns, Wu Yusheng Named Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487885","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487885?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:05","pubTimestamp":1786968349,"startTime":"0","endTime":"0","summary":"TYK Medicines non-executive director Jiang Mingyu resigns, Wu Yusheng named authorized representativeTYK Medicines announced the resignation of non-executive director Jiang Mingyu, effective Aug. 17, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL6XfymN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126200437","title":"TYK Medicines Sets 17 August 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1126200437","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126200437?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:27","pubTimestamp":1785922076,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc will convene its board of directors on 17 August 2026 to review and approve the consolidated interim results for the six months ended 30 June 2026. The agenda also includes...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132829978","title":"TYK Medicines Reports No Share Capital Changes in July 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1132829978","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132829978?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:27","pubTimestamp":1785922065,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (H shares, stock code 02410) filed its Monthly Return for the period ended 31 July 2026, confirming that both registered and issued share capital remained stable during the month....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657151224","title":"TYK Medicines Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2657151224","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657151224?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:16","pubTimestamp":1785921390,"startTime":"0","endTime":"0","summary":"TYK Medicines schedules board meeting to review interim results, consider dividendTYK Medicines will hold a board meeting on Aug. 17, 2026 to review interim results for the six months ended June 30, 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL3cSQw9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128214014","title":"TYK Medicines-B Shares Surge Over 5% as Qilu Pharma Secures Exclusive Rights for Lung Cancer Drug TY-9591","url":"https://stock-news.laohu8.com/highlight/detail?id=1128214014","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128214014?lang=en_us&edition=fundamental","pubTime":"2026-07-27 13:20","pubTimestamp":1785129624,"startTime":"0","endTime":"0","summary":"TYK Medicines-B (02410.HK) saw its share price jump more than 6% during intraday trading, currently up 5.39% to HKD 7.23, with a trading volume of HKD 17.57 million. Qilu Pharmaceutical has secured...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TY","BK1161","09939","BK1515","02410","BK1191","159938","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104146430","title":"TYK Medicines files dual court actions to invalidate alleged TY-9591 agreements with Sichuan Huiyu Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1104146430","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104146430?lang=en_us&edition=fundamental","pubTime":"2026-07-22 23:00","pubTimestamp":1784732430,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (TYK Medicines) has initiated legal proceedings in the People’s Court of Changxing County, seeking judicial confirmation that a purported cooperation agreement and distribution...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151541342","title":"TYK MEDICINES-B Initiates Legal Proceedings Against Sichuan Huiyu Pharmaceutical Co., Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=1151541342","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151541342?lang=en_us&edition=fundamental","pubTime":"2026-07-22 23:00","pubTimestamp":1784732427,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (ASX: 02410) has announced that the company recently filed a case with the Changxing County People's Court, initiating legal proceedings against Sichuan Huiyu Pharmaceutical Co., Ltd....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","01477","BK1191","BK1161","BK1515","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033766","title":"Tyk Medicines - Files Legal Proceedings Against Sichuan Huiyu Pharmaceutical over Ty-9591 Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653033766?lang=en_us&edition=fundamental","pubTime":"2026-07-22 22:53","pubTimestamp":1784731998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O18N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653766081","title":"TYK Medicines Sues Huiyu Pharma over Disputed Ty-9591 Cooperation Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2653766081","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653766081?lang=en_us&edition=fundamental","pubTime":"2026-07-22 22:52","pubTimestamp":1784731955,"startTime":"0","endTime":"0","summary":"TYK Medicines sues Huiyu Pharma over disputed TY-9591 cooperation dealTYK Medicines filed suit in Changxing County court against Huiyu, seeking a ruling that purported TY-9591 cooperation and distribu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDLbHtXyx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}]}}